Assessing the potential of bone marrow concentrate for cartilage repair and regeneration in animal models : a systemic review
Bone marrow concentrate (BMC) has been emerging as a promising regenerative source to accelerate cartilage regeneration in cartilage injuries and osteoarthritis. Though the number of stem cells in BMC is limited, BMC is rich in growth factors that promote stem cell differentiation and tissue regen...
Saved in:
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Penerbit Universiti Kebangsaan Malaysia
2021
|
Online Access: | http://journalarticle.ukm.my/17537/1/19.pdf http://journalarticle.ukm.my/17537/ https://www.ukm.my/jsm/malay_journals/jilid50bil6_2021/KandunganJilid50Bil6_2021.html |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Universiti Kebangsaan Malaysia |
Language: | English |
Summary: | Bone marrow concentrate (BMC) has been emerging as a promising regenerative source to accelerate cartilage
regeneration in cartilage injuries and osteoarthritis. Though the number of stem cells in BMC is limited, BMC is rich in
growth factors that promote stem cell differentiation and tissue regeneration. Despite of multiple reports available on
the use of BMC for cartilage repair in humans and its use in clinical settings, only limited number of pre-clinical proof
of concept studies have been reported in animal models. Hence, a systematic review focusing on the potential of BMC
for the treatment of cartilage defect in animal models has been conducted. The systematic search of literature using
three popular databases, ISI Web of Knowledge, PubMed and Scopus, were conducted without year restriction. Fifteen
(n = 15) studies were found appropriate and included in this review. All of the included studies were of different animal
models with cartilage defect. 13 out of 15 studies reported that the usage of BMC gave the best outcome compared to
other treatment methods. Most of the findings provided good scoring on the tissue repair and the histological outcome.
However, most of the BMC group outcomes did not give a significant difference when compared with other interventions
such as the addition of platelet rich plasma, erythropoietin, hyaluronic acid, transforming growth factor, autologous tissue
implant, genetic modification or scaffoldings. In conclusion, the published studies do suggest that BMC could provide a
better cartilage repair. However, more preclinical studies are required to provide definitive conclusions. |
---|